ARCHIVES

Trastuzumab Increases Risks Of Congestive Heart Failure

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

Glaxo, Mass General Begin Phase III Trial Of Tykerb

December 29, 2006

Carbone Heads Chairmen’s Group

June 30, 1978

“Treatment INDs” Seen As Major Threat To Clinical Trials

August 21, 1987

ODAC Discussion: NCI’s Richard Simon Cautions About Rules Of Thumb

January 30, 2009

NCI-Approved Clinical Trials

January 26, 2007

Worker Health RFA May Finally Be Ready

August 26, 1988